These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 21544767)

  • 1. [Examination of the stability of medically unexplained symptoms and somatoform disorders over time within the context of different diagnostic concepts].
    Steinbrecher N; Hiller W
    Psychother Psychosom Med Psychol; 2011 Aug; 61(8):356-63. PubMed ID: 21544767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating new proposals for the psychiatric classification of patients with multiple somatic symptoms.
    Rief W; Mewes R; Martin A; Glaesmer H; Brähler E
    Psychosom Med; 2011; 73(9):760-8. PubMed ID: 22048838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which factors predict the persistence of DSM-IV depression, anxiety, and somatoform disorders in the medically ill three months post hospital discharge?
    McKenzie M; Clarke DM; McKenzie DP; Smith GC
    J Psychosom Res; 2010 Jan; 68(1):21-8. PubMed ID: 20004297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of somatoform symptoms--implications for classification.
    Rief W; Rojas G
    Psychosom Med; 2007 Dec; 69(9):864-9. PubMed ID: 18040096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification characteristics of the Patient Health Questionnaire-15 for screening somatoform disorders in a primary care setting.
    Körber S; Frieser D; Steinbrecher N; Hiller W
    J Psychosom Res; 2011 Sep; 71(3):142-7. PubMed ID: 21843748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of DSM-IV criteria in primary care patients with medically unexplained symptoms.
    Smith RC; Gardiner JC; Lyles JS; Sirbu C; Dwamena FC; Hodges A; Collins C; Lein C; Given CW; Given B; Goddeeris J
    Psychosom Med; 2005; 67(1):123-9. PubMed ID: 15673634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value of DSM IV and DSM 5 criteria for diagnosing the most prevalent somatoform disorders in patients with medically unexplained physical symptoms (MUPS).
    Claassen-van Dessel N; van der Wouden JC; Dekker J; van der Horst HE
    J Psychosom Res; 2016 Mar; 82():4-10. PubMed ID: 26944392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The outcome of medically unexplained symptoms--will DSM-V improve on DSM-IV somatoform disorders?
    Creed F
    J Psychosom Res; 2009 May; 66(5):379-81. PubMed ID: 19379953
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence, impact, and prognosis of multisomatoform disorder in primary care: a 5-year follow-up study.
    Jackson JL; Kroenke K
    Psychosom Med; 2008 May; 70(4):430-4. PubMed ID: 18434494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [DSM-5: from 'somatoform disorders' to 'somatic symptom and related disorders'].
    van der Feltz-Cornelis CM; van Houdenhove B
    Tijdschr Psychiatr; 2014; 56(3):182-6. PubMed ID: 24643828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relation between anger management style, mood and somatic symptoms in anxiety disorders and somatoform disorders.
    Koh KB; Kim DK; Kim SY; Park JK; Han M
    Psychiatry Res; 2008 Sep; 160(3):372-9. PubMed ID: 18718675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatoform disorders: 30 years of debate about criteria! What about children and adolescents?
    Schulte IE; Petermann F
    J Psychosom Res; 2011 Mar; 70(3):218-28. PubMed ID: 21334492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive validity and clinical utility of DSM-5 Somatic Symptom Disorder--comparison with DSM-IV somatoform disorders and additional criteria for consideration.
    Voigt K; Wollburg E; Weinmann N; Herzog A; Meyer B; Langs G; Löwe B
    J Psychosom Res; 2012 Nov; 73(5):345-50. PubMed ID: 23062807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression, anxiety, and somatoform disorders: vague or distinct categories in primary care? Results from a large cross-sectional study.
    Hanel G; Henningsen P; Herzog W; Sauer N; Schaefert R; Szecsenyi J; Löwe B
    J Psychosom Res; 2009 Sep; 67(3):189-97. PubMed ID: 19686874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatoform syndromes and disorders in a representative population sample of adolescents and young adults: prevalence, comorbidity and impairments.
    Lieb R; Pfister H; Mastaler M; Wittchen HU
    Acta Psychiatr Scand; 2000 Mar; 101(3):194-208. PubMed ID: 10721868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Course and prediction of somatoform disorder and medically unexplained symptoms in primary care.
    Steinbrecher N; Hiller W
    Gen Hosp Psychiatry; 2011; 33(4):318-26. PubMed ID: 21762827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relation between the patient health questionnaire-15 and DSM somatic diagnoses.
    Liao SC; Huang WL; Ma HM; Lee MT; Chen TT; Chen IM; Gau SS
    BMC Psychiatry; 2016 Oct; 16(1):351. PubMed ID: 27756342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatoform disorders among first-time referrals to a neurology service.
    Fink P; Steen Hansen M; Søndergaard L
    Psychosomatics; 2005; 46(6):540-8. PubMed ID: 16288133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the diagnostic concepts of ICD-10 somatoform disorders and DSM-5 somatic symptom disorders in patients from a psychosomatic outpatient clinic.
    Hüsing P; Löwe B; Toussaint A
    J Psychosom Res; 2018 Oct; 113():74-80. PubMed ID: 30190052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are psychological features useful in classifying patients with somatic symptoms?
    Rief W; Mewes R; Martin A; Glaesmer H; Braehler E
    Psychosom Med; 2010 Sep; 72(7):648-55. PubMed ID: 20368474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.